The novel treatment of the medication represents a major development in the handling of the condition. Different to existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide198210.blogprodesign.com/63455091/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment